Interstitial Lung Disease (ILD) is difficult to diagnose and treat. At first, the disease could look like a variety of other disorders, such asfibrosis or autoimmunity. Once a diagnosis is made, a decision on how aggressively to treat it can mean the difference betweenirreversible lung damageor overlyimpactingyour patient's quality of life. We caught up with Dr. Robert Hallowell, a Pulmonary and Critical Care physician at the Massachusetts General Hospitaland Director of the Interstitial Lung Disease Program atthe Pulmonary Ambulatory Clinic. Dr. Hallowelltellsus how heevaluates ILD
Podden och tillhörande omslagsbild på den här sidan tillhör
American College of Rheumatology. Innehållet i podden är skapat av American College of Rheumatology och inte av,
eller tillsammans med, Poddtoppen.